Skip to main content

and
  1. No Access

    Article

    Naoxintong Capsule for Secondary Prevention of Ischemic Stroke: A Multicenter, Randomized, and Placebo-Controlled Trial

    To examine whether the combination of Naoxintong Capsule with standard care could further reduce the recurrence of ischemic stroke without increasing the risk of severe bleeding.

    **ao-fei Yu, Xu-ying Zhu, Can-xing Yuan in Chinese Journal of Integrative Medicine (2022)

  2. No Access

    Article

    Effect of integrated Chinese and Western medicine therapy on severe hand, foot and mouth disease: A prospective, randomized, controlled trial

    To evaluate the efficacy and safety of Chinese medicine (CM) plus Western medicine (WM) in the treatment of pediatric patients with severe hand, foot and mouth disease (HFMD) by conducting a prospective, contr...

    **u-hui Li, Shuang-jie Li, Yi Xu, Dan Wei in Chinese Journal of Integrative Medicine (2017)

  3. Article

    Population pharmacokinetics of moxifloxacin and its concentration–QT interval relationship modeling in Chinese healthy volunteers

    Moxifloxacin (MX) is an 8-methoxyquinolone antimicrobial drug, which is often used as a positive control in thorough QT (TQT) studies. In the present study we established the population pharmacokinetics model ...

    Feng-yan Xu, Ji-han Huang, Ying-chun He, Li-yu Liang in Acta Pharmacologica Sinica (2017)

  4. No Access

    Article

    Limited sampling strategy models for estimating the AUC of gliclazide in Chinese healthy volunteers

    The aim of this work is to reduce the cost of required sampling for the estimation of the area under the gliclazide plasma concentration versus time curve within 60 h (AUC0−60t ). The limited samp...

    Ji-Han Huang, Kun Wang, **ao-Hui Huang in European Journal of Drug Metabolism and Ph… (2013)

  5. Article

    Dose findings of antofloxacin hydrochloride for treating bacterial infections in an early clinical trial using PK-PD parameters in healthy volunteers

    To find an appropriate dose regimen of the novel antibacterial agent antofloxacin for a phase II clinical trial using a population pharmacokinetic (PPK) study in healthy volunteers and the minimum inhibitory c...

    Yun-fei Li, Kun Wang, Fang Yin, Ying-chun He, Ji-han Huang in Acta Pharmacologica Sinica (2012)

  6. No Access

    Article

    PK-PD modeling of irbesartan in healthy Chinese adult volunteers under non-steady-state conditions

    The purpose of this study was to construct a pharmacokinetic/pharmacodynamic model (PK-PD model) of irbesartan in healthy Chinese adult volunteers under non-steady-state conditions and provide relevant PK/PD p...

    **ao-Hui Huang, Jun Li, Fu-Rong Qiu in European Journal of Drug Metabolism and Ph… (2006)